by In2Pharma | Sep 6, 2017 | News
EU As from the third quarter of 2018, also purely national marketing authorization applications have to be submitted in eCTD format. For follow-up procedures (e.g. variations, renewal applications) of these national procedures, the switch to electronic format will be...
